2,2'-azobis(2-amidinopropane) has been researched along with probucol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gotoh, N; Niki, E; Noguchi, N | 1 |
| Dailly, E; Tillement, JP; Urien, S | 1 |
| Koga, T; Moro, K; Terao, J | 1 |
3 other study(ies) available for 2,2'-azobis(2-amidinopropane) and probucol
| Article | Year |
|---|---|
Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals.
Topics: Amidines; Antioxidants; Apolipoproteins B; Arteriosclerosis; Azoles; Copper; Free Radicals; Humans; In Vitro Techniques; Isoindoles; Lipoproteins, LDL; Organoselenium Compounds; Oxidation-Reduction; Probucol | 1994 |
Chain-breaking antioxidants and ferriheme-bound drugs are synergistic inhibitors of erythrocyte membrane peroxidation.
Topics: Adult; Amidines; Antioxidants; Ascorbic Acid; Chloroquine; Deferoxamine; Drug Synergism; Erythrocyte Membrane; Fatty Acids; Female; Hemin; Humans; Linoleic Acid; Lipid Peroxidation; Male; Membrane Lipids; Oxidation-Reduction; Oxygen Consumption; Oxyhemoglobins; Probucol; Pyridines; Reperfusion Injury; Vitamin E | 1998 |
Protective effect of a vitamin E analog, phosphatidylchromanol, against oxidative hemolysis of human erythrocytes.
Topics: Amidines; Antioxidants; Butylated Hydroxytoluene; Chromans; Erythrocyte Membrane; Erythrocytes; Free Radicals; Glycerophospholipids; Hemolysis; Humans; In Vitro Techniques; Oxidants; Oxidation-Reduction; Phosphatidic Acids; Probucol; Vitamin E | 1998 |